Maze Therapeutics Earnings
NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
26.25-0.18 (-0.68%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 26.25 0.00%
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.78
Maze Therapeutics earnings summary
Maze Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.78.
Summary generated from market data by MetaCap's automated system. Methodology